MARKET

MNPR

MNPR

Monopar Therapeutics Inc
NASDAQ
72.68
+0.95
+1.32%
After Hours: 74.83 +2.15 +2.96% 16:24 11/12 EST
OPEN
70.11
PREV CLOSE
71.73
HIGH
75.03
LOW
67.12
VOLUME
313.02K
TURNOVER
--
52 WEEK HIGH
124.82
52 WEEK LOW
50.07
MARKET CAP
487.84M
P/E (TTM)
-33.4931
1D
5D
1M
3M
1Y
5Y
1D
Cantor upgrades Monopar Therapeutics on recent pullback, added clarity
TipRanks · 5h ago
Monopar Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
TipRanks · 6h ago
Monopar Therapeutics GAAP EPS of -$0.72 in-line
Seeking Alpha · 10h ago
*Monopar Therapeutics: Runway To Support Operations Through at Least March 2028 >MNPR
Dow Jones · 11h ago
*Monopar Therapeutics 3Q Loss $6.2M >MNPR
Dow Jones · 11h ago
Weekly Report: what happened at MNPR last week (1102-1106)?
Weekly Report · 3d ago
Weekly Report: what happened at MNPR last week (1026-1030)?
Weekly Report · 11/02 10:21
Weekly Report: what happened at MNPR last week (1019-1023)?
Weekly Report · 10/26 10:21
More
About MNPR
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.

Webull offers Monopar Therapeutics Inc stock information, including NASDAQ: MNPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNPR stock methods without spending real money on the virtual paper trading platform.